Reaction Details Report a problem with these data
Target
Cannabinoid receptor 2
Ligand
BDBM334295
Substrate
n/a
Meas. Tech.
In Vitro Assay
EC50
8100±n/a nM
Citation
 Macielag, MJ; Zhang, Y; DeCorte, BL; Greco, MN; Ludovici, DW; Parker, MH Cinnoline derivatives useful as CB-1 receptor inverse agonists US Patent  US9732061 Publication Date 8/15/2017 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM334295
Synonyms:
US9732061, Compound 17
Type:
Small organic molecule
Emp. Form.:
C33H28Cl2N4O2
Mol. Mass.:
583.507
SMILES:
OC(=O)c1ccc(cc1)N1CCC(CC1)Nc1cnnc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Structure:
Search PDB for entries with ligand similarity: